[ET Net News Agency, 20 February 2024] JD HEALTH (06618) rose 3.2% to HK$29.05.
It hits an intra-day high of HK$29.05, and an intra-day low of HK$27.7. The total shares
traded was 2.26 million, with a value of HK$64.21m. The active buy/sell ratio is 53:47,
with net buying turnover of HK$3.63m. BARCLAYS CAPITAL ASIA accounts for greatest net
responsive buying turnover of HK$4.82m, with volume weighted average price of HK$28.456.
MERRILL LYNCH FE accounts for greatest net responsive selling turnover of HK$7.5m, with
volume weighted average price of HK$28.434.
RMB counter of JD HEALTH (86618) rose 2.5% to RMB26.65.
The Hang Seng Index now rose 67 points, or 0.4% to 16,222; the Hang Seng China
Enterprises Index now rose 28 points, or 0.5% to 5,513; the Hang Seng TECH Index now rose
9 points, or 0.3% to 3,262.
Basic Information
=================
---------------------------------
Nominal 29.050 % Chg +3.20%
High 29.050 Low 27.700
Shares Tr 2.26m Turnover 64.21m
10-D SMA 28.375 %H.V 64.334
20-D SMA 27.875 VWAP 28.434
50-D SMA 32.190 RSI14 48.676
---------------------------------
Status: Active buy/sell ratio is 53:47, with net buying turnover of HK$3.63m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
JD HEALTH (06618) 29.05 +3.20
ALI HEALTH (00241) 3.43 +3.94
CSPC PHARMA (01093) 6.15 +0.65
SINOPHARM (01099) 21.65 +1.17
SINO BIOPHARM (01177) 3.09 -0.32
CHINARES PHARMA (03320) 5.25 +2.54
HANSOH PHARMA (03692) 13.26 +0.30
SCICLONE PHARMA (06600) 12.72 +1.27
GOLDEN THROAT (06896) 3.35 +1.52
JD HEALTH-R (86618) RMB26.65 +2.50
-----------------------------------------------
(ed)